For more details on the courses, please refer to the Course Catalog
| Code | Course Title | Credit | Learning Time | Division | Degree | Grade | Note | Language | Availability |
|---|---|---|---|---|---|---|---|---|---|
| IPS5022 | Pricing and Reimbursement Policy | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | Korean | Yes |
| The course provides critical understanding of the entire process of health technology assessment, pricing and reimbursement.. This course covers theory and practice, pricing and competition, comparing prices, pricing and reimbursement in Korea market, process for successful pricing and reimbursement. | |||||||||
| IPS5023 | International Pricing and Reimbursement Policy | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | - | No |
| This course aims to give students an understanding of the approaches to pricing adopted by pharmaceutical companies and the legal and customary framework found in different countries, and to provides students with the skills to assess the price at which a pharmaceutical could be sold in particular market. | |||||||||
| IPS5025 | Econometrics in Health care | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | - | No |
| This course focuses on understanding causal relationship between health-related variables and developing analytical skills in handling observational data in health care. It not only covers basic theory on linear regression, but also extends to relaxing the classical linear regression model. | |||||||||
| IPS5027 | Topics in Pharmacoeconomics | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | Korean | Yes |
| This course ranges from cost-effectiveness and cost-benefit analyses to cost-utility analysis. It will cover the basic appreciation of the nature of economic evaluation and its relevance to health care decision making on all levels. | |||||||||
| IPS5030 | Law in Pharmaceutical Industry | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | - | No |
| The objective of the course is to provides critical understanding of law in drug development. This course studies pharmaceutical affairs law related pharmaceutical industry. | |||||||||
| IPS5041 | Pharmaceutical Internship | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | Korean | Yes |
| For the vacation period, Achieve short term internship in domestic and global enterprise related pharmaceutical industry. | |||||||||
| IPS5043 | Advanced Studies in Biological Drugs | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course will help students understand the fundamental and concepts of biological regulation. Student can learn the procedures, issues and initiative that will have an impact on regulatory strategy. The program offers information with a regulatory focus on the many different calsses of biologics. Topic include: biologic submissions, guidelines. ICH CTD | |||||||||
| IPS5046 | ICH/CTD | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | - | No |
| The course is designed to find strategy for global expansion of domestic pharmaceutical industry by understanding current management status and guidelines of ICH. Topic include ICH organization and guidelines, international cooperation such PIC/s, and CTD regulations and writing methods. | |||||||||
| IPS5047 | Regulatory Strategy in Global Market1 | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course has been development to provide a comprehensive understanding of regulatory environment throughout other countries(USA, Europe, Japan etc). Topics include: The structure of other countries regulatory environment, business strategies to maximize the value of product in other countries prior to licensing or understanding the concern/issues of Regulatory Personnel, information required for effective submission. | |||||||||
| IPS5048 | Regulatory Strategy in Global Market2 | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | - | No |
| This course has been development to provide a comprehensive understanding of regulatory environment throughout other countries(China, Asia, Latin American etc). Topics include: The structure of other countries regulatory environment, business strategies to maximize the value of product in other countries prior to licensing or understanding the concern/issues of Regulatory Personnel, information required for effective submission. | |||||||||
| IPS5052 | Strategy in Pharmaceutical Patent | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | - | No |
| The course is designed to analysis issue of drug approval – patent linkage system by the comprehensive understanding of intellectual poverty system and patent system. Topic include strategy for achievement of intellectual poverty and patent, drug approval – patent linkage system, technology licensing, evaluation of technology value and business strategy for pharmaceutical technology in pharmaceutical industry. | |||||||||
| IPS5055 | Pharmaceutical Industry Policy | 3 | 6 | Major | Master/Doctor | 1-4 | Industrial Pharmaceutical Science | - | No |
| Focuses on the application of economic theory and applied research to the international and domestic pharmaceutical industry. Economic theory provides the background for the analysis of industry structure and behavior and the impact of changes in regulatory and other policies. This course also provides an economic perspective on such issues as regulation, pricing, research and development, product innovation, patient policies, and profitability. | |||||||||
| IPS5057 | Pharmceutical Technology Valuation | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course emphasizes the understanding of essential parameters for valuating pharmaceutical technologies such as such as R&D cost, success rate and sales curve forecasting as well as understanding the basic theories and methodologies for technology valuation. The goal of this course is understanding the methodologies for pharmaceutical technology area through studying the real case for pharmaceutical project valuations and dealing exercise project. | |||||||||
| IPS5059 | Entrepreneurship in Biotechnology | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course introduces the theory and practice of management and strategic issues for the entrepreneurship in biotechnology start-ups such as venture capital (VC), strategic alliance, licensing contract, outsourcing management, IPO and M & A. It also aims to understand the structure of bio-venture industry and characteristics of venture companies through learning about key business areas in bio-ventures such as vaccines, antibody therapeutics and cell therapy. | |||||||||
| IPS5060 | Strategic Marketing in Pharmaceutical Industry | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course aims to learn the marketing competence needed in the field of pharmaceutical industry through studying the strategic marketing and the marketing research in the pharmaceutical industry. Students will learn marketing strategies such as portfolio strategy, drug life cycle management and marketing research techniques such as market forecasting and market analysis and marketing techniques for successful commercialization through practical training on marketing cases. | |||||||||